Students: Isabel Hedayat
Type of project: Mind and Body, Translational, Clinical Trial
Grant Type: Undergraduate
Year of Award: 2015, 2016
Supervisor: Dr. Oates
Institutions Affiliated: University of Saskatchewan
Description: Gait and mobility issues are prevalent not only in movement disorders like Parkinsons, but in normal aging populations. This project seeks to evaluate a novel physical therapy intervention, haptic anchoring, against the current standard practice, both quantitatively (gait improvement measures) but also qualitatively (to understand how people responded to haptic anchoring). This project could act as a precursor for a full scale clinical trial of haptic anchoring (which involves using balls on strings that dangle near the floor to provide additional sensory feedback when walking).
People with Parkinson's Disease often struggle to walk properly, since the part of their brain important for initiating movement decays. But why walk when you can dance? Paradoxically, many people with Parkinson's can still dance to music. Check out the video on the right to see this in action. Abulosono is a music-based biofeedback program that uses this important feature of music to help re-train the brain's of people with Parkinson's to walk normally.
Kailie Luan, Undergraduate Student
Dr. Bin Hu
University of CalgaryDr. Hu's Website
Think about how critical walking is to your every day life. From the moment you wake up, you have to walk around your home, around your neighborhood, and your community. For people with Parkinson's, simply walking down the hall can feel as challenging as walking for miles up a steep hill. Successfully getting down the hall can be a draining act, and many people might feel too frustrated to even try sometimes. Ambulosono can help make walking a much more manageable task for people with Parkinson's, which in turn can greatly increase their overall quality of life. While there are medications that can help out with Parkinson's, they are often only work for a while. Having another option, like Ambulosono, can help people reduce their dosage, or save drug-based approaches for later in life when they might be more necessary.
So far, Ambulosono has had some very promising initial findings at multiple different research sites. The next step is to start to scale things up so that this treatment can be brought to a wider range of people struggling from Parkinson's Disease.
Amount Funded: $16,000Support Innovative Research by Donating Today!
If you have Parkinson's, one of the best ways to learn about this NeurCAM would be to participate in an Ambulosono study.